As a control, normalizing DSCAM gene dosage did not change the increased level of amyloid precursor protein (APP) in Ts65Dn (S1A Fig), which is encoded by another HSA21 gene that is important for brain disorders of DS [36]. This evidence concerns the gene DSCAM and Dravet syndrome.